FREDERICK, Md., Feb. 5, 2013 /PRNewswire/ -- BioElectronics Corporation (BIEL: OTCPink), maker of consumer medical devices, announced today that easyMed s.r.o has begun sales and distribution of the ActiPatch® Musculoskeletal Pain Relief and RecoveryRx™ Postoperative and Wound Care Therapy brands in the Czech and Slovak Republic.
easyMed s.r.o. employs 16 sales representatives that cover the entire Czech Republic nation and has access to numerous physician and orthopedic clinics and pharmacies. The company also owns a large share of the medical market and is the leading supplier of viscosupplement products.
"Our company provides superior quality medical products to physicians and patients. We believe that expanding our product portfolio with the ActiPatch® and RecoveryRx™ products will accelerate our momentum in new innovative products and provide outstanding value to our customers", said Marek Kozurik, CEO.
easyMed s.r.o. represents well known medical brands such as Anika Therapeutics, Fidia Advanced Biologics, Estar Medical and B.Braun, a supplier of medical supplies to hospitals, physicians and the homecare market.
"We are delighted to add easyMed s.r.o to our growing list of skilled and successful international distributors, said Ben Fichter , Marketing Manager. "We are certain that the Czech Republic will embrace a safe, drug free, inexpensive product that provides 5x's more effective pain relief than OTC drug therapy and is 100% safer.
About BioElectronics Corporation
BioElectronics is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and accelerate healing. For more information, please visit www.bielcorp.com.
|SOURCE BioElectronics Corporation|
Copyright©2012 PR Newswire.
All rights reserved